Phaarmasia Limited (BOM:523620)
76.63
-0.38 (-0.49%)
At close: Aug 17, 2026
Phaarmasia Market Cap
Phaarmasia has a market cap or net worth of 523.15 million as of August 17, 2026. Its market cap has increased by 190.27% in one year.
Market Cap
523.15M
Enterprise Value
424.52M
Revenue
486.03M
Ranking
n/a
PE Ratio
2.97
Stock Price
76.63
ChartMarket Cap Chart
Since April 13, 1998, Phaarmasia's market cap has increased from 13.70M to 523.15M, an increase of 3,718.00%. That is a compound annual growth rate of 13.70%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 17, 2026 | 523.15M | -32.03% |
| Dec 31, 2025 | 769.67M | 132.45% |
| Dec 31, 2024 | 331.11M | 23.19% |
| Dec 29, 2023 | 268.78M | 41.36% |
| Dec 30, 2022 | 190.13M | -15.73% |
| Dec 31, 2021 | 225.63M | -8.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Source Natural Foods and Herbal Supplements | 731.88M |
| Asston Pharmaceuticals | 680.61M |
| Biofil Chemicals and Pharmaceuticals | 531.18M |
| Mangalam Drugs & Organics | 450.31M |
| Parmax Pharma | 440.54M |
| JFL Life Sciences | 435.54M |
| Shelter Pharma | 424.29M |
| Vista Pharmaceuticals | 424.09M |